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We investigate the use of hybrid techniques in complex processes of infectious diseases. Since pre-
dictive disease models in biomedicine require a multiscale approach for understanding the molecule-
cell-tissue-organ-body interactions, heterogeneous methodologies are often employed for describing
the different biological scales. Hybrid models provide effective means for complex disease mod-
elling where the action and dosage of a drug or a therapy could be meaningfully investigated: the
infection dynamics can be classically described in a continuous fashion, while the scheduling of mul-
tiple treatment discretely. We define an algebraic language for specifying general disease processes
and multiple treatments, from which a semantics in terms of hybrid dynamical system can be de-
rived. Then, the application of control-theoretic tools is proposed in order to compute the optimal
scheduling of multiple therapies. The potentialities of our approach are shown in the case study of the
SIR epidemic model and we discuss its applicability on osteomyelitis, a bacterial infection affecting
the bone remodelling system in a specific and multiscale manner. We report that formal languages
are helpful in giving a general homogeneous formulation for the different scales involved in a mul-
tiscale disease process; and that the combination of hybrid modelling and control theory provides
solid grounds for computational medicine.
1 How many scales does it take to describe an epidemics?
In this work we investigate multi-methodology approaches for the modelling of complex infectious dis-
eases and for finding the best strategy of intervention, able to avoid or limit the spread of the disease
and its effect on the affected organisms. Infectious diseases can be broadly classified into three groups
(Fig. 1): acute, latent persistent and chronic persistent. Acute diseases like the common cold, the Rhi-
novirus, the Yellow Fever, the Influenza or some strains of the Staphylococcus Aureus (Osteomyelitis)
are characterized by a single disease episode after which they do not occur anymore. Latent persistent
ones like the Herpes simplex, the Varicella-zoster or the Measles-SSPE arises also after the first disease
episode and a non-infectious and latent period. Chronic persistent diseases (e.g. Hepatitis B, HIV, HTLV-
1 leukemia, chronic Osteomyelitis) can protract their effects on the host organism for several years.
Epidemic modelling is one of the most established tools for predicting the progress and the spread
of a disease in large populations, which are commonly divided into compartments:Susceptible, Exposed,
Infected and Recovered. According to the possible flows among such compartments, different variants
arises, like the SIR (Susceptible→Infected→Recovered) model [12], SIS, SIRS, SEIR and SEIRS. Fur-
ther compartments can be taken into account like the population of immune infants, usually indicated
with M. Similar compartments can be identified not only at the human population level, but also at the
cellular population level, where the pathogen typically acts by infecting susceptible cells. As a matter of
fact, infections are characterized by multiscale dynamics that affect the organism at multiple levels in the
biological hierarchy, as shown on the left side of Fig. 2: at the intracellular level, in case of infection of a
cell by a pathogen; at the intercellular/cellular population level, in case of infection of susceptible cells
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Figure 1: Simplified classification of infectious diseases. The disease intensity follows a Gaussian curve
approximately partitioned in three stages. In the first one, the infection starts but any symptom is re-
ported. In the second one called “disease episode” symptoms are reported and the disease can be trans-
mitted to other individuals. In the last stage, the disease is over if it is acute or latent persistent. However
some diseases can become chronic.
by infected cells; at the tissue level, when multi-cellular ensembles are involved; at the organ/individual
level, when infection spreads to other parts of the body; and at the human population level, if the disease
is transmitted among individuals. A further scale above the human population one could be the con-
sciousness level for which several psychological and cognitive behaviour models exists. Just consider
that psychological states like fear or stress can even affect (negatively) the immune system: a demonstra-
tion that all the scales in the biological hierarchy are intimately connected to each other. Their inherent
multiscale dynamics make the modelling of infective processes a challenging and intriguing field of re-
search. Indeed, pathogens and infective agents generally act at the cellular scale, but they need to exploit
mechanisms at the human population level to spread and survive in other host organisms.
1.1 Formal languages, hybrid modelling and control in multiscale infectious diseases
We believe that hybrid modelling could help in unravelling the complexity of the multiscale dynamics
occurring in such diseases. We refer to ’hybrid modelling’ not just with its classical meaning, i.e. the
modelling of those systems characterized by the co-existence of continuous and discrete dynamics, but
also with a methodological meaning. In multiscale systems different scales are typically approached
with different methodologies, thus leading to the co-existence of heterogeneous modelling techniques, in
other words to a methodologically hybrid modelling approach. The cellular level is typically represented
with agent-based or ordinary differential equation models, while the tissue and organ levels are often
described using image-based finite element modelling (partial differential equations). In the context
of disease modelling the determination of suitable intervention strategies, including drug and therapy
administration, adds another level of description that affects multiple biological scales.
This kind of integrative models are composed of single-scale models, describing the biological pro-
cess at different characteristic space-time scales, and scale bridging models, which define how the single-
scale models are coupled to each other [22]. Higher level languages and formalisms can help in giving a
general homogeneous formulation for the different scales in a multiscale biological system. In general,
that formal description cannot be directly executed or simulated, but it is able to support multiple seman-
tics (e.g. transition systems, differential equations and Markov chains). In particular process-algebraic
languages are a formal notation initially developed for modelling software systems, but in the last decade
it has been extensively used and extended in order to describe biological systems. In a seminal paper [7],
Cardelli showed that a subset of stochastic CCS is powerful enough to encode both systems of reactions
in the stoichiometric form and systems of ordinary differential equations. Additionally, a recent work of
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Figure 2: Modelling of multiscale infective dynamics. Infections involve the intracellular level (a cell
infected by a pathogen); the intercellular level (infection among cells); the tissue level (infection among
collections of cells); the organ level (infection among different parts of the body); and the human popu-
lation level (transmission among individuals). Each biological scale can be implemented with different
modelling techniques like Gillespie’s SSA, Continuous Time Markov Chains (CTMC), ordinary/partial
differential equations (ODE/PDE), agent-based models (ABM), or finite state machines (FSM). Such
heterogeneous semantics can be wrapped by a common formal language.
the authors [18, 19] demonstrates the effectiveness of a hybrid approach where a process-algebraic spec-
ification level is translated into a runnable stochastic agent-based model in the bone remodelling case
study, while in [2] the same case study is approached with different semantics according to the biological
property to analyse.
Consequently, formal languages could represent a wrapping language able to homogeneously de-
scribe the different scales of a complex multiscale system, where each level can be instantiated into
a runnable model according to the most suitable semantics. Figure 2 sketches the idea of the hetero-
geneous semantics associated to a multiscale model of infection through a common formal language.
Furthermore, the importance of being hybrid in the classical sense is demonstrated by several biologi-
cal evidences. For instance, genetic regulatory networks naturally exhibits hybrid dynamics, for which
the continuous concentration of proteins is interrupted by the discrete switches dictated by changes in
gene expression [3, 10]. Moreover in population biology it happens that some species are present in
high concentration, so they can be approximately modelled by continuous variables; conversely, small
populations are opportunely modelled as discrete stochastic variables [14].
Another crucial aspect is related to the self-regulation and control of biological systems: in normal
conditions, biological entities and functions are self-regulated and several multiscale control mechanisms
naturally exists. One of the most striking example is the control operated by the immune system that
protect the organism in case of disease. In fact, lymphocytes are able to detect the presence of a pathogen
and produce an appropriate immune response by secreting immunoglobulins. However, in many cases
of severe diseases the immune system cannot apply an effective control anymore. Drugs and therapies
represent a form of control which is external to the organism and is extremely significant when dealing
with models of diseases that can be limited by appropriate medical interventions. The control operated by
medical therapies can be much more effective but needs to formulate control laws that take into account
their (negative) impact on the organism due to possible side effects. While the drug administration
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strategy is determined at the human population level, the therapy affects multiple lower scales (in most
of the cases, the cellular and subcellular scale). Other examples of multiscale control are the mechanical
control at the organ and tissue level that regulates the functioning of bone cells in the bone remodelling
process; or in an infection scenario, the cognitive behaviour at the human level that avoids or limits the
interactions with other individuals possibly affected by the disease. A work by Bagnoli et al. [1] embeds
this aspect of human behaviour into a SIR epidemic model by allowing individuals to perceive the risk
of being infected by ill neighbours. Therefore, the use of control-theoretic tools seems promising for
describing the biological mechanisms of multiscale self-regulation and self-adaptiveness, as well as for
implementing externally imposed control mechanisms.
In this work we present a general model for complex multiscale infectious diseases and for scheduling
optimal medical treatments. We employ a hybrid modelling approach both in the classical and in the
methodological sense. Indeed, we formulate the disease process by means of a high-level process algebra
called D-CGF, from which a hybrid (in the classical sense) semantics can be derived. This semantics is
given in terms of a hybrid dynamical system, where the cell population and the infection dynamics are
described in a continuous fashion, while the dosage of multiple therapies is implemented as discrete
switches. Then, we propose the application of model predictive control (MPC) tools for computing the
optimal scheduling of multiple therapies. The potentialities of our approach are shown in the case study
of the SIR epidemic model and we discuss its applicability on the case study of osteomyelitis, a bacterial
infection affecting the bone remodelling system.
The paper is organized as follows. Section 2 presents the algebraic language D-CGF for generic
disease processes and its semantics in terms of hybrid dynamical systems, by means of the SIR example.
Section 3 reports the optimal controlled solutions for scheduling multiple therapies in the SIR model and
show how this approach can be useful to the osteomyelitis case study. Discussions and conclusions are
given in Section 4.
2 General process-algebraic formulation of infectious diseases
In this part we propose a generic formulation of complex infectious diseases, by defining a variant of
the Chemical Ground Form (CGF) stochastic process algebra. Stochastic process algebras extend clas-
sical ones with quantitative information in form of action rates and have associated a Continuous Time
Markov Chains (CTMC) semantics from which a continuous and less computationally demanding ap-
proximation in terms of ODE can be derived. The multiplicity of semantics it supports has made formal
process-algebraic languages one of the most used tools in biological modelling. A work by Cardelli [7]
shows how several encodings can be implemented among specifications in the CGF algebra (a subset of
stochastic CCS), systems of reactions in the stoichiometric form and ODE systems. Bortolussi and Poli-
criti [6] extend this work by defining a semantics in terms of hybrid automata [11], defining the requisites
according to which a set of processes can be treated as discrete control states, while others have the usual
continuous interpretation. Several other methods for associating hybrid semantics to quantitative process
algebras have been proposed, among which [9, 5].
The formal modelling language employed in this paper is called Disease Chemical Ground Form (D-
CGF), and it is a variant of CGF for describing complex disease processes. Differently from [17], where
a stochastic process algebra and its continuous semantics are used to describe a classical epidemic model,
we attempt to provide a framework for more generic diseases and, although the syntax of D-CGF does
not radically differ from that of CGF, we define a novel constructive procedure for deriving a semantics
in terms of hybrid dynamical systems, by distinguishing the following two kinds of processes:
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S ::= 0 | X = I,S Set of species definition
I ::= 0 | pi.P+ I Individual species
P ::= 0 |(X‖P) Population
pi ::= τr | ?xr | !xr Actions
T ::= 0 |U = R,T Set of therapy definition
R ::= 0 | pi.C+R Therapy
C ::= 0 |(U‖C) Combination of therapies
D−CGF ::= (S,P,T,C) A D-CGF model
Table 1: Syntax of D-CGF.
• Individuals: standard CGF processes that belong to some species and that collectively represent the
population in the disease model. Different species can describe for instance the various compart-
ments of an epidemic model (susceptible, infected, and etc.), a pathogen, or a particular mutation.
Individuals are interpreted as continuous variables in the hybrid semantics.
• Therapies: processes for modelling interventions on the disease scenario. They could represent
for instance the dosage of a drug or a change in the environment that discretely alter the disease
dynamics. Based on the hybrid semantics of CGF [6], therapy processes are subject to some
restrictions in order to be interpreted as the discrete switches of the hybrid dynamical system.
D-CFG will be illustrated by means of an epidemic example, even if this language is suitable to describe
also models of virus infection, infectious cancers or other kinds of diseases where discrete intervention
policies has to be modelled.
2.1 The Disease Chemical Ground Form
Here we present the Disease Chemical Ground Form (D-CGF), a variant of the Chemical Ground Form
(CGF) [8]) targeted to describe complex models of disease in a process-algebraic fashion. The syntax of
D-CGF is given by the grammar in Table 1. A D-CGF model is given by a set of species S, an initial
population P, a set of therapies T , and an initial combination of therapies C. The first notable difference
from the algebra CGF is that in D-CGF models two disjoint sets of processes are distinguished:
• the set of species (a set of individual species definitions), the individual species and the population
(the parallel composition of individuals); and
• the set of therapy definitions, the therapy and the combination of therapies (the parallel composi-
tion of therapies).
Individual species and therapies are defined by the alternative composition (+) of action-prefixed terms.
Actions pi ∈ Π are indexed by a quantity r corresponding to the rate of the exponential distribution that
determines their duration, and are the usual ones: τr (internal action), ?xr (input action) and !xr (output
action). The motivation for separating these two sets of processes is related to the hybrid semantics
of D-CGF: species are interpreted as continuous variables, while therapies as discrete control states.
In addition we will need to put some restrictions on the therapy processes, for formally justifying this
separation. In the remainder of this section, a simple epidemic model will serve as the running example
for illustrating our approach.
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S→b S+S
I→b I+S Birth of susceptible
R→b R+S
S→µ /0 Death of susceptible
I→µ /0 Death of infected
R→µ /0 Death of recovered
S+ I→β I+ I Infection of susceptible
I→ν R Infected becomes recovered
Table 2: Reactions in the SIR epidemic model with open population and no disease-dependent death rate.
2.1.1 D-CGF by example
In this part, we illustrate some of the technical features of the algebra by means of an epidemic example:
the SIR (Susceptible→Infected→Recovered) model [12]. It describes the dynamics at the epidemiolog-
ical level of a population consisting of individuals susceptible to the disease (S), those infected (I) and
those recovered (R). Here we consider an open-population (i.e. with births and deaths) SIR model, given
by the list of reactions in Table 2.
According to the conversion rules for CGF, we can translate this list of reactions in a D-CGF model
M = (S,P,0,0) with no therapies.
S :
S = τbS1 .(S‖S) + τ
µ
S2
.0 + ?iβ .I
I = τbI1 .(I‖S) + τ
µ
I2
.0 + !iβ .I + τνI3 .R
R = τbR1 .(R‖S) + τ
µ
R2
.0
P : P0,
where P0 is the initial population. Given an action pi ∈Π, we denote with react(pi) the multiset of species
consumed by pi , with prod(pi) the multiset of those produced by pi . #(X ,P) denotes the number of X
occurring in the population P. ∆(pi,X) = #(X , prod(pi))− #(X ,react(pi)) denotes the net variation of
X due to pi . For instance in the above example, react(i) = {S, I}, prod(i) = {I, I}, ∆(i,S) = −1 and
∆(i, I) = 1.
The procedure for extracting a system of ODEs requires to build the so-called stoichiometric matrix
M, which has one row for each species and one column for each action. A cell M[X ,pi] takes the net
variation of X due to pi: ∆(pi,X). Then a rate vector φ has to be defined in the following way. Let r(pi)
denote the rate of action pi . Then for each action pi ∈Π,
φ [pi] =

0 if react(pi) = /0
r(pi)X if react(pi) = {X}
r(pi)XY if react(pi) = {X ,Y}
r(pi)X(X−1) if react(pi) = {X ,X}
Finally, the differential equations are given by X˙ = M ·φ . The stoichiometric matrix, the rate vector and
the resulting ODEs for the SIR example are shown below.
M =

τS1 τI1 τR1 τS2 τI2 τR2 τI3 i
S 1 1 1 −1 0 0 0 −1
I 0 0 0 0 −1 0 −1 1
R 0 0 0 0 0 −1 1 0
 φ =

τS1 bS
τI1 bI
τR1 bR
τS2 µS
τI2 µI
τR2 µR
τI3 νI
i βSI

S˙ = bN−βSI−µS
I˙ = βSI−µI−νI
R˙ = νI−µR
(N = S+ I+R)
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S+T 1on→ρ R+T 1on Susceptible becomes recovered with therapy 1
I+T 2on→k R+T 2on Infected becomes recovered with therapy 2
T 1o f f →r1on T 1on Therapy 1 switched on
T 1on→r1o f f T 1o f f Therapy 1 switched off
T 2o f f →r2on T 2on Therapy 2 switched on
T 2on→r2o f f T 2o f f Therapy 2 switched off
Table 3: Additional therapy-specific reactions in the SIR epidemic model with open population and
medical treatments at Table 2.
Now we modify the SIR example in order to include two therapies T 1 and T 2 that makes immune
the susceptible population and increase the mutation rate from infected to recovered, respectively. T 1on
(T 2on) and T 1o f f (T 2on) denote the therapy being administered or not, respectively. Therefore, T 1 can
be thought as a vaccination that makes immune the susceptible individuals, while T 2 as a therapy for
combating the course of the disease. The therapy-specific reactions introduced are listed in Table 3. In
this case, the associated D-CGF model M = (S,P,T,C) has been extended with the therapy processes
and is defined as follows:
S :
S = τbS1 .(S‖S) + τ
µ
S2
.0 + ?iβ .I + ? jρ .R
I = τbI1 .(I‖S) + τ
µ
I2
.0 + ?τνI3 .R + !i
β .I + ?hk.R
R = τbR1 .(R‖S) + τ
µ
R2
.0
P : P0
T :
T 1o f f = τr1on1on .T 1on
T 1on = ! jρ .T 1on + τ
r1o f f
1o f f .T 1o f f
T 2o f f = τr2on2on .T 2on
T 2on = !hν+k.T 2on + τ
r2o f f
2o f f .T 2o f f
C : T 1o f f ‖ T 2o f f
2.2 Hybrid semantics of D-CGF
In the following we will give the definition of switching therapy (ST), and show that STs constitute the
discrete switches in the hybrid dynamical system semantics where the different species are the continuous
variables. The definition of switching therapy is broadly inspired by the notion of Control Automata [6],
i.e. the control structure that can be identified in the hybrid automata-based semantics of a CGF model.
We also provide a constructing procedure for determining the STs associated to a D-CGF model and
therefore its semantics in terms of hybrid dynamical systems.
In order to interpret the set therapy terms T as a set of discrete switches, we need to identify collec-
tions of terms in which exactly one term is active in every combination of therapies reachable from the
initial one. We call such a collection a Switching Therapy (ST). The intuition is that a switching therapy
models a discrete component whose terms represent its internal states, since exactly one of them must
be active at each step. We give the definition of ST and of well-formed therapies for imposing additional
restrictions on the construction of therapy terms in order to ensure a correct discrete interpretation of
them.
Definition 1 (Switching Therapy) LetM = (S,P,T,C) be a D-CGF model, and Ti ⊆ T a set of therapy
terms. Ti is a Switching Therapy (ST) if the following conditions hold:
1. Exactly one of the terms U ∈ Ti is active in the initial combination of therapies: #(Ti,C) =
∑U∈Ti #(U,C) = 1.
P. Lio`, E. Merelli & N. Paoletti 159
2. Each action must conserve the concentration of terms in Ti and cannot involve more than one
reagent in Ti: ∀pi ∈Π.(#(Ti,react(pi)) = #(Ti, prod(pi))≤ 1).
3. For each action pi ∈Π such that U1 ∈ react(pi) and U2 ∈ prod(pi), with U1,U2 ∈ Ti, U1 6=U2 =⇒
(react(pi) = {U1}∧ prod(pi) = {U2}).
Conditions 1+2 ensure that exactly one term of the ST is active in every reachable configuration, since
condition 1 requires that the initial concentration of Ti-terms must be equal to one and condition 2 tells
that such concentration is conserved. Additionally, condition 2 implies that there are no actions able to
modify the concentration of Ti-terms and thus that the internal state of the ST Ti can be changed only by
actions having a Ti-term in its reactants. Finally, condition 3 requires that every action causing the switch
of a Ti-term from U1 to U2 must be an internal action of U1, of the form U1 = . . .+ τ.U2+ . . ..
Definition 2 (Well-formed therapies) LetM = (S,P,T,C) be a D-CGF model and let C =U1‖ . . .‖Un,
with n≥ 1. T is a set of well-formed therapies if there exists a partition T = {T1, . . . ,Tn} of T such that
Ti ∈T is a switching therapy and Ui ∈ Ti, for all i = 1, . . . ,n.
We present a method for extracting the switching therapies and show how the semantics in terms hybrid
dynamical systems can be constructed. Given a D-CGF model M = (S,P,T,C), the procedure exploits
the stoichiometric matrix M, with which it is easy to check the conservation of switching terms and
condition 3 of Definition 1. Some necessary conditions has to be formulated on M for ensuring the
well-formedness of T .
Definition 3 (Necessary conditions for well-formedness) LetM = (S,P,T,C) be a D-CGF model and
M be the associated stoichiometric matrix. Then, the following conditions are necessary for the well-
formedness of T
1. The elements of M restricted to T take values in {−1,0,1}: ∀pi ∈ Π. ∀U ∈ T. M|T [U,pi] ∈
{−1,0,1}.
2. Conservation of T -terms: ∀pi ∈Π. ∑U∈T M[U,pi] = 0;
3. Exclusive switch (1): ∀pi ∈ Π. ∃≤1U ∈ T. M[U,pi] = −1. This condition and the conservation
condition additionally imply that it exists exactly one V ∈ T such that M[V,pi] = 1.
4. Exclusive switch (2): ∀pi ∈Π. (∃U ∈ T. M[U,pi] =−1 =⇒ (∀X ∈ S.M[X ,pi] = 0∧pi internal)).
The stoichiometric matrix M associated to the SIR example with therapies is given below.
M =

τS1 τI1 τR1 τS2 τI2 τR2 τI3 τ1on τ1o f f τ2on τ2o f f i j h
S 1 1 1 −1 0 0 0 0 0 0 0 −1 −1 0
I 0 0 0 0 −1 0 −1 0 0 0 0 1 0 −1
R 0 0 0 0 0 −1 1 0 0 0 0 0 1 1
T 1o f f 0 0 0 0 0 0 0 −1 1 0 0 0 0 0
T 1on 0 0 0 0 0 0 0 1 −1 0 0 0 0 0
T 2o f f 0 0 0 0 0 0 0 0 0 −1 1 0 0 0
T 2on 0 0 0 0 0 0 0 0 0 1 −1 0 0 0

It is easy to check that the conditions listed above are met in M.Such conditions on the stoichiometric
matrix are not sufficient to ensure the well-formedness of the set of therapies T . Indeed, Def. 3 corre-
sponds to stating that the whole set T meets conditions 2+3 in the definition of switching therapy, but it
is not possible from the only stoichiometric matrix to prove also condition 1 (exactly one term in T is
active in the initial configuration). Moreover recalling that T is well-formed if it can be partitioned into
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a set of switching therapies, such necessary conditions are defined on the entire set of therapies T , thus
considering only the trivial partition {T}.
The algorithm for extracting the STs consists in building a graph G = (T,E) called ST-graph, where
T is the set of process terms and arcs connect couples (U1,U2) of therapy terms that are involved in a
switch, i.e. M[U1,pi] =−1 and M|T [U2,pi] = 1 for some pi .
Definition 4 (ST-graph) Let M = (S,P,T,C) be a D-CGF model and M be the associated stoichio-
metric matrix. The ST-graph GM = (T,E) associated to M is a directed graph whose vertices are the
T -terms ofM and E = {(U1,U2) ∈ T ×T | ∃pi ∈Π. (M[U1,pi] =−1∧M|T [U2,pi] = 1)}.
Now it is possible to check the well-formedness of T by considering the set of connected components
of GM , C (GM ) (see Proposition 5). In particular, if the stoichiometric matrix M meets the necessary
conditions in Def. 3 and the set of connected components C (GM ) = {G1, . . . ,Gn} is such that for each
Gi there is exactly one term active in the initial configuration, then T is well-formed and the nodes of
each Gi form a switching therapy. Note that the sets of nodes of the connected components in an ST-
graph form, by definition, a partition of T . This is necessary to guarantee that, according to Def. 2, a set
well-formed therapies can be partitioned into a set of switching therapies. In addition, the therapy terms
in each Gi meet the Condition 2 of Def. 1 about the conservation of terms in a switching therapy, because
the connected components Gi are (of course) mutually disconnected, i.e. there cannot exist any arc in the
ST-graph connecting them that is, no terms can flow between them.
Proposition 5 Let M = (S,P,T,C) be a D-CGF model, M be the associated stoichiometric matrix,
C (GM ) = {G1 = (T1,E1), . . . ,Gn = (Tn,En)} be the set of connected components of the associated ST-
graph GM and T = {T1, . . . ,Tn}. T is well-formed and each Ti ∈ T is a switching therapy if the
following conditions hold:
1. M meets the necessary requirements at Def. 3;
2. for each Ti ∈ T , exactly one of the terms in Ti is active in the initial combination of therapies:
#(Ti,C) = 1; and
3. for each Ti ∈ T and for each action pi ∈ Π, the number of Ti-terms in react(pi) is at most one:
#(Ti,react(pi))≤ 1.
The ST-graph for the SIR example is given in Fig. 3 (a). It is straightforward to check that its
connected components are such that exactly one term in each Gi is active in the initial combination of
therapies C = T 1o f f | T 2o f f ; and that for each Gi there is no action pi whose reactants involve more
than one term in Gi. Therefore the set of therapy definitions T of the SIR example is well-formed and
T = {{T 1o f f ,T 1on},{T 2o f f ,T 2on}} is the set of switching terms.
The combination of the different switching therapies allows us to extract the possible discrete modes
in the hybrid semantics. We define a mode graph structure as the Cartesian product of the switching
terms in a ST-graph. Figure 3 (b) shows the mode graph for the SIR example.
Definition 6 (Mode graph) Let M = (S,P,T,C) be a D-CGF model and C (GM ) = {G1, . . . ,Gn} be
the set of connected components of the associated ST-graph. The mode graph MGM is defined by the
Cartesian product G1× . . .×Gn.
Note that transitions between modes could have associated exponentially distributed delays determined
by the stochastic rates of the algebraic specification. In our context, we omit them assuming that such
transitions are instantaneous, also because discrete modes will represent the control inputs of the hybrid
dynamical system semantics.
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G1
G2
T1on T1off
T2on T2off
(a)
T1on T2on
T1off T2on
T1on T2off
T1off T2off
(b)
Figure 3: ST-graph for the SIR example (a) and its corresponding mode graph (b). The connected
components of the ST-graph are such that there is exactly one term in each Gi active in C and for each
Gi, no action pi involves more than one Gi-term in react(pi). This ensures that T is well formed and
the connected nodes are switching therapies. In (b) four distinct discrete modes are generated from the
Cartesian product of G1 and G2.
As pointed out also in [6], Petri Nets could have been similarly applied in order to study the con-
servation properties in a switching therapy. In particular, a set of switching therapies could be seen as a
set of strictly conservative (i.e. constant number of tokens) and 1-bounded (i.e. the maximum number of
token is 1) Petri Nets.
2.2.1 Hybrid dynamical system of D-CGF models
Here we describe the semantics of a D-CGF model in terms of a particular class of hybrid dynamical
systems, called controlled switched systems (CSS) [16]. While in the general formulation of hybrid
dynamical system the external control input and the discrete operation mode are distinct, in a CSS the
external controller produces a switching signal (i.e. the discrete mode) that is given in input to the plant
(i.e. the controlled system). The basic form of a controlled switched system is the following:
x˙ =f(x,q)
y =g(x,q),
where x∈Rn is the continuous state, f is a vector-valued smooth function, g is the output function and q is
the discrete operation mode. The above equations are often written with the form x˙ = fq(x) y = gq(x),
stressing the different dynamics and outputs under different operation modes. Note that a controlled
switched system can also be seen as a hybrid dynamical system with controlled discrete inputs. Figure 4
shows the control loop in a CSS. We show how to derive a CSS from a D-CGF model, by following
the method elaborated by Cardelli for the CGF algebra as regards the continuous part of the semantics,
but considering also the switching therapies and the mode graph as regards the discrete part. Recalling
that each node of a mode graph MGM = ({q1 = {U11, . . . ,U1n}, . . . ,qk = {Uk1, . . . ,Ukm}},E) models a
particular combination of therapies, a mode qi being active means that therapies U ∈ qi are active and
that those in T \qi are not. Therefore a modified version of the rate vector will be used:
φqi = φ [1upslopeU ,0upslopeV ], U ∈ qi,V ∈ T \qi,
which is obtained by zeroing all the elements of φ that contain a therapy term not belonging to qi, and
omitting (substitution with 1) those in q1 . The resulting controlled switched system would be:
x˙ = fqi(x) = M|S ·φqi ,
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x = f(x, q)
y = g(x, q)
.System
Controller
(Therapy  
scheduler)
q(Combinationof therapies) y (Observables, e.g.patient medical data)
Figure 4: Control loop in a controlled switched system. The plant defines the piecewise smooth dynamics
of the system x˙ and the observable output y. The output could represent patient’s medical data obtained
after a visit. Depending on y, the controller acts as therapy scheduler and determines the operation mode
q (e.g. a particular combination of therapies) of the plant.
where qi ∈MGM is a node of the mode graph, and M|S is the stoichiometric matrix restricted to the set
of species S. The operation modes q, the modified rate vector φq and the resulting CSS x˙ of the SIR
example are shown below.
φq =

τS1 τI1 τR1 τS2 τI2 τR2 τI3 τ1on τ1o f f τ2on τ2o f f i j h
q1 bS bI bR µS µI µR νI r1on 0 r2on 0 βSI 0 0
q2
...
...
...
...
...
...
... 0 r1o f f r2on 0
... ρS 0
q3
...
...
...
...
...
...
... r1on 0 0 r2o f f
... 0 kI
q4 bS bI bR µS µI µR νI 0 r1o f f r2o f f 0 βSI ρS kI

q =

q1 = (T 1o f f ,T 2o f f )
q2 = (T 1on,T 2o f f )
q3 = (T 1o f f ,T 2on)
q4 = (T 1on,T 2on)
 x˙(q1) =

S˙ = bN−βSI−µS
I˙ = βSI−µI−νI
R˙ = νI−µR
x˙(q2) =

S˙ = bN−βSI−µS−ρS
I˙ = βSI−µI−νI
R˙ = νI−µR+ρS
x˙(q3) =

S˙ = bN−βSI−µS
I˙ = βSI−µI− (ν+ k)I
R˙ = (ν+ k)I−µR
x˙(q4) =

S˙ = bN−βSI−µS−ρS
I˙ = βSI−µI− (ν+ k)I
R˙ = (ν+ k)I−µR+ρS
Alternatively, we could consider the equivalent formulation which exploits the sets of switching terms
{T 1o f f ,T 1on} and {T 2o f f ,T 2on} as discrete control variables in the following way.
T1(qi)=
{
1 if T 1on ∈ qi
0 if T 1o f f ∈ qi T2(qi)=
{
1 if T 2on ∈ qi
0 if T 2o f f ∈ qi x˙(qi)=

S˙ = bN−βSI−µS−T1(qi)ρS
I˙ = βSI−µI− (ν+T2(qi)k)I
R˙ = (ν+T2(qi)k)I−µR+T1(qi)ρS
Note that this form is applicable because in the SIR example each switching term contains exactly two
terms and can consequently have assigned a value in {0,1}.
3 Hybrid semantics and optimal control of infectious processes
In this section we define the optimal control law for therapy scheduling in the SIR model by means of
Model Predictive Control (MPC) [4], and we report the optimally controlled solutions with parameters
that are typical of the measles [20]. A similar problem has been addressed in [21] for the scheduling of
hormone therapy in a model for prostate cancer.
In order to cope with the nonlinear dynamics of the SIR model, the optimal scheduling of multiple
therapies is computed by solving an on-line MPC problem in the Multi-Parametric Toolbox (MPT) [13].
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The optimal control law can be formulated by means of the following constrained finite-time optimal
control (CFTOC) problem, where the original continuous-time dynamics is simply discretized with the
Euler method:
min
u
∑T−1k=0 ‖Ru(k)‖1 +‖Qx(k)‖1
sub j. to x(k) ∈ [0,1]3
u(k) ∈ {0,1}2
x(T ) ∈Xset
x(k+∆t) = Ax(k)+Bu(k)
∀k = 0, . . . ,T
A =
1+(b−β I(k)−µ)∆t b∆t b∆t0 1+(βS(k)−µ−ν)∆t 0
0 ν∆t 1−µ∆t

B =
−ρS(k)∆t 00 −kI(k)∆t
ρS(k)∆t kI(k)∆t
 Q =
1 0 00 10 0
0 0 0.5

where ∆t = 1/365 is the discrete time step corresponding to one day; u(k) = [T 1(k) T 2(k)]T ∈ {0,1}2
is the discrete input (the combination of the two therapies) and x(k) = [S(k) I(k) R(k)]T ∈ [0,1]3 is the
systems’ continuous state vector at time k; T = 3 is the prediction horizon (corresponding to three days);
Xset is a polytope identifying the set of terminal states; ‖x‖1 = |S|+ |I|+ |R| and ‖u‖1 = |T 1|+ |T 2|;
R and Q are the weights on the controlled inputs and on the system state, resp. The terminal set Xset
represents an invariant on the final states and can be described by the convex hull of its vertices: Xset =
Conv({[1 0 0]T , [0 0 1]T}). In this way, the terminal set contains all the states [S I R]T such that I = 0 (no
infected individuals), S,R≥ 0 and S+R = 1 (we do not exceed the population limit). Matrix Q has been
set so that the state variable Infected has associated a weight equals to 10 and thus is slightly penalized
over variables Susceptible (weight 1) and Recovered (weight 0.5). Finally, we assume for simplicity that
the internal state can be observed and we set the output vector y to the state vector x.
Matrix R allows us to implement different therapy scheduling strategies. The higher R, the higher
penalty is given to drug dosage. In particular if R is assigned a large value, then the strategy is to avoid
drug dosage as much as possible. This can be the case of a therapy with severe side effects or of a
patient in an early stage of the disease that can be treated even with a small dosage. On the contrary, a
low value to R leads to a strategy where drug dosage is much more prominent (e.g. little side effects or
mature stage of disease). Additionally we can assign different weights to different drugs according to
their therapeutic impact on the patient, thus possibly enabling a wider spectrum of control strategies. We
computed the optimally controlled solutions considering three scenarios obtained by varying the weights
on the controlled therapies:
1. Low penalties to T 1 and T 2: R =
[
0.1 0
0 0.1
]
2. High penalty to T 1: R =
[
100 0
0 0.1
]
3. High penalty to T 2: R =
[
0.1 0
0 100
]
Results reported in Figure 5 tell that solutions under scenario 1 and scenario 2 are the same (Fig. 5
(a)), suggesting that therapy T 1 does not need to be administered in the optimal strategy of treatment in
order to fulfil the terminal constraints. Indeed Fig. 5 (b) shows that when T 2 has a high weight (scenario
3), no control moves are performed, so indicating that T 1 is ineffective with respect to T 2.
3.1 Osteomyelitis, a truly multiscale infection
Osteomyelitis is a a bone pathology caused by bacteria infection (mostly Staphylococcus aureus) that
alters the bone remodelling process and that rapidly leads to severe bone loss, necrosis of the affected
portion, and it may even spread to other parts of the body. Therefore it is one of the most appropriate
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(a) Scenarios 1,2 (b) Scenario 3
Figure 5: Optimally controlled solutions for the SIR model with therapies as controlled discrete inputs
simulated for 15 days. Parameters are: S(0) = 0.3, I(0) = 0.7, R(0) = 0, b = µ = 0.02, β = 1800, ν =
100, ρ = 0.5, k = 50. Results have been computed by using a global optimal nonlinear solver.
examples of multiscale infection, since it affects multiple biological scales. Indeed infection by S. au-
reus starts at the intracellular level, but it subsequently involves also the tissue and the organ level. Bone
remodelling (BR) is the cellular-level process by which the bone is continuously renewed as the result of
an alternation of bone resorption, conducted by cells called osteoclasts, and bone formation, conducted
by osteoblasts. They form together the so-called Basic Multicellular Unit (BMU), i.e. an ensemble of
osteoclasts and osteoblasts that dissolve an area of the bone surface and then fill it. The BMU could be
considered as an emerging scale intermediate between the cell and tissue levels. Osteomyelitis induces a
severe inflammatory response followed by progressive bone destruction and loss of the vasculature and
with a persistent chronic infection; this is further complicated by the rapid emergence of resistant strains
of S. aureus. It has been shown that the infection prevents proliferation, induces apoptosis and inhibits
mineralisation of cultured osteoblasts. Although effective treatment of this disease is very difficult, one
of most used drug is the fusidic acid that acts as a bacteriostatic agent, and is usually combined with other
antibiotics. Based on a recent work of the authors about the modelling of osteomyelitis and the compar-
ison of different treatments [15], we can define a hybrid version of that model and a treatment strategy
combining antibiotic and anti-inflammatory therapies. The model describes how the bone remodelling
dynamics of osteoblasts’ (Ob) and osteoclasts’ (Oc) population is affected by the S.aureus (B).
x =
OcOb
B
 u = [T 1T 2
] O˙c = α1Og11(1+ f11 Bs )c Og21(1+T 2·ki− f21 Bs )b −β1Oc,
O˙b = α2O
g12/(1+ f12 Bs )
c O
g22− f22 Bs
b −β2Ob,
B˙ = (1−T 1)γBB · log( sB ) y =−k1 ·Oc+ k2 ·Ob,
where αi and βi are growth and death rates; gi j describes the effectiveness of autocrine and paracrine
regulation, i.e. the chemical interactions between osteoblasts and osteoclasts; fi j models the impact of
the infection on the autocrine and paracrine regulation; T 1 is the discrete input modelling the antibiotic
dosage; T 2 models the dosage of a anti-inflammatory therapy; ki is the effectiveness of therapy T 2; the
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bacterial population follows a Gompertz curve with carrying capacity s and growth rate γB; and the output
function y represents the bone density calculated as a function of Oc, Ob and their resorption (k1) and
formation (k2) rates. Bone Mineral Density (BMD) measurement are often taken in medical practice,
thus y is the quantity observed by the controller (a doctor who administers the treatment) after each visit.
The optimal scheduling of bacteriostatic and anti-inflammatory therapies could be formulated with a
control law similar to the SIR example. Since the combination of antibiotic and anti-inflammatory drugs
has never been applied in medical practice, we could set the weight matrix of input therapies R so that
R12 and R21 are much larger that R11 and R22. In this way, we give a high penalty to the combination of
therapies T 1 and T 2 w.r.t. T 1 and T 2 taken individually.
4 Discussion and conclusion
The field of predictive models in biomedicine is challenged by the need of a better comprehension of
the phenomenon of scales in the biological organisation, particularly their role in the transition between
health and disease conditions. The multiscale modelling of molecules-cell-tissue-organ-body interac-
tions is a key step in the process of identifying the most important parameters acting in a disease state
and their calibration, linking basic research and clinical practice (therapies). Here we discuss how a de-
scription based on hybrid dynamical systems is beneficial to the formulation of a multiscale modelling in
biomedical processes. A second instance of the utility of hybrid dynamics approach stems from the pres-
ence of multiple controls in biological systems. These controls could be framed as occurring naturally
(the immune system response) or induced after the administration of a therapy. It is very often the case
of multiple treatments, i.e. switching between therapies or combination of therapies which is the case
considered in this study. In particular, we show the suitability of the D-CGF high-level process algebra
to accomplish the task: here, its semantics is given in terms of a hybrid dynamical system where the
large number of cell populations provides the basis for a continuous modelling approach and the dosage
of multiple therapies is implemented as discrete switches.
We believe that this approach opens several interesting directions in basic and clinical research.
First, it is general and could be used for different tissues and organs or multiorgan diseases. Second, it is
possible to extend the mathematical formulation to all the scales of biological organisation involved in
the infection and recovery conditions. Third, the therapy could be complex and built on several nested
and hierarchical protocols. One final comment: given the richness of examples provided by biological
processes and medical therapies, there is basis for deriving interesting theories. We remind the bon mot
of Stan Ulam: Ask not what mathematics can do for biology. Ask what biology can do for Mathematics.
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